ANG Lifesciences India Limited (ANG.BO)
INR 26.31
(-2.01%)
INR 26.31
(-2.01%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 671.01 Million INR | -7.4% |
| 2022 | 724.64 Million INR | -5.46% |
| 2021 | 766.49 Million INR | 78.18% |
| 2020 | 430.17 Million INR | 115.32% |
| 2019 | 199.78 Million INR | 28.84% |
| 2018 | 155.06 Million INR | -2.73% |
| 2017 | 159.42 Million INR | 21.67% |
| 2016 | 131.02 Million INR | 4.27% |
| 2015 | 125.65 Million INR | 10.18% |
| 2014 | 114.05 Million INR | -3.4% |
| 2013 | 118.06 Million INR | -7.72% |
| 2012 | 127.94 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q3 | 69.32 Million INR | -90.22% |
| 2023 Q1 | 61.77 Million INR | -91.48% |
| 2023 Q4 | 671.01 Million INR | 867.88% |
| 2023 Q2 | 709.07 Million INR | 1047.83% |
| 2023 FY | 671.01 Million INR | -7.4% |
| 2022 Q1 | 66.52 Million INR | -91.32% |
| 2022 FY | 724.64 Million INR | -5.46% |
| 2022 Q4 | 724.64 Million INR | 1106.14% |
| 2022 Q3 | 60.08 Million INR | -91.79% |
| 2022 Q2 | 732.1 Million INR | 1000.54% |
| 2021 Q2 | 875.15 Million INR | 2165.49% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 766.49 Million INR | 0.0% |
| 2021 FY | 766.49 Million INR | 78.18% |
| 2021 Q1 | 38.62 Million INR | -91.02% |
| 2020 FY | 430.17 Million INR | 115.32% |
| 2020 Q4 | 430.17 Million INR | 0.0% |
| 2020 Q1 | 186.91 Million INR | -6.44% |
| 2020 Q2 | 186.91 Million INR | -0.0% |
| 2019 Q1 | 168.51 Million INR | 8.67% |
| 2019 Q3 | 172.32 Million INR | 2.26% |
| 2019 Q4 | 199.78 Million INR | 15.93% |
| 2019 Q2 | 168.51 Million INR | 0.0% |
| 2019 FY | 199.78 Million INR | 28.84% |
| 2018 Q4 | 155.06 Million INR | -11.54% |
| 2018 FY | 155.06 Million INR | -2.73% |
| 2018 Q3 | 175.3 Million INR | 31.79% |
| 2018 Q2 | 133.01 Million INR | 0.0% |
| 2018 Q1 | 133.01 Million INR | -16.56% |
| 2017 Q1 | 124.42 Million INR | -5.04% |
| 2017 Q2 | 124.42 Million INR | 0.0% |
| 2017 Q3 | 159.42 Million INR | 28.13% |
| 2017 Q4 | 159.42 Million INR | 0.0% |
| 2017 FY | 159.42 Million INR | 21.67% |
| 2016 FY | 131.02 Million INR | 4.27% |
| 2016 Q3 | 131.02 Million INR | 26.85% |
| 2016 Q2 | 103.29 Million INR | 0.0% |
| 2016 Q1 | 103.29 Million INR | 0.0% |
| 2016 Q4 | 131.02 Million INR | 0.0% |
| 2015 FY | 125.65 Million INR | 10.18% |
| 2014 FY | 114.05 Million INR | -3.4% |
| 2013 FY | 118.06 Million INR | -7.72% |
| 2012 FY | 127.94 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Add-Shop E-Retail Limited | 116.24 Million INR | -477.225% |
| Bacil Pharma Limited | 569 Thousand INR | -117828.471% |
| Beryl Drugs Limited | 48.7 Million INR | -1277.624% |
| Cian Healthcare Limited | 544.97 Million INR | -23.128% |
| Colinz Laboratories Limited | -64.3 Million INR | 1143.517% |
| Concord Drugs Limited | 164.48 Million INR | -307.943% |
| Deccan Health Care Limited | -7.07 Million INR | 9582.942% |
| Gennex Laboratories Limited | -552.54 Million INR | 221.44% |
| Gujarat Terce Laboratories Limited | 37.76 Million INR | -1676.859% |
| Ishita Drugs and Industries Limited | -48.09 Million INR | 1495.095% |
| Kerala Ayurveda Limited | 447.82 Million INR | -49.837% |
| Kwality Pharmaceuticals Limited | 921.75 Million INR | 27.203% |
| Mercury Laboratories Limited | -26.72 Million INR | 2610.431% |
| Panchsheel Organics Limited | -157.82 Million INR | 525.173% |
| Parmax Pharma Limited | 51.8 Million INR | -1195.144% |
| Parnax Lab Limited | 787.61 Million INR | 14.805% |
| Patidar Buildcon Limited | 25.12 Million INR | -2570.592% |
| Pharmaids Pharmaceuticals Limited | 37.28 Million INR | -1699.541% |
| Phaarmasia Limited | -4.89 Million INR | 13802.532% |
| Sandu Pharmaceuticals Limited | -11.43 Million INR | 5970.63% |
| Sastasundar Ventures Limited | -297.24 Million INR | 325.741% |
| SHELTER PHARMA LIMITED | -44.62 Million INR | 1603.704% |
| Source Natural Foods and Herbal Supplements Limited | -58.58 Million INR | 1245.347% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.04 Billion INR | 35.907% |
| Sunil Healthcare Limited | 625.4 Million INR | -7.293% |
| Syschem (India) Limited | 3.53 Million INR | -18898.103% |
| Trident Lifeline Limited | 117.56 Million INR | -470.783% |
| Transchem Limited | -3.16 Million INR | 21314.448% |
| Tyche Industries Limited | -788.94 Million INR | 185.052% |
| Vikram Thermo (India) Limited | 38.62 Million INR | -1637.25% |
| Vasundhara Rasayans Limited | -76.15 Million INR | 981.138% |
| Zenith Healthcare Limited | -25.45 Million INR | 2735.868% |
| Zenotech Laboratories Limited | -196.85 Million INR | 440.863% |
| Hindustan Bio Sciences Limited | 25.21 Million INR | -2561.341% |
| KIMIA BIOSCIENCES LIMITED | 431.72 Million INR | -55.425% |
| Chemo Pharma Laboratories Limited | -6.05 Million INR | 11176.477% |
| MedPlus Health Services Limited | 8.67 Billion INR | 92.268% |
| Sanjivani Paranteral Limited. | -85.95 Million INR | 880.702% |
| Smruthi Organics Limited | 111.28 Million INR | -502.946% |
| Trimurthi Limited | -1.17 Million INR | 57052.385% |
| Zenlabs Ethica Limited | 139.54 Million INR | -380.854% |
| Makers Laboratories Limited | 172.59 Million INR | -288.788% |
| Lactose (India) Limited | 373.97 Million INR | -79.429% |
| Bharat Immunologicals & Biologicals Corporation Limited | 689.39 Million INR | 2.666% |
| Roopa Industries Limited | 216.01 Million INR | -210.633% |
| PANJON LTD. | -12.8 Million INR | 5339.015% |
| TIAAN CONSUMER LIMITED | 13.44 Million INR | -4890.8% |
| Anuh Pharma Limited | -69.8 Million INR | 1061.24% |
| Crestchem Limited | -1.45 Million INR | 46376.759% |
| Emmessar Biotech & Nutrition Limited | -60.73 Million INR | 1204.876% |
| PRAVEG LIMITED | -434.98 Million INR | 254.26% |
| Fredun Pharmaceuticals Limited | 1.04 Billion INR | 35.727% |
| Shukra Pharmaceuticals Limited | -68.26 Million INR | 1082.953% |
| Norris Medicines Limited | 214.86 Million INR | -212.3% |
| Denis Chem Lab Limited | -236.28 Million INR | 383.985% |
| Veerhealth Care Limited | -2.38 Million INR | 28234.717% |
| Jenburkt Pharmaceuticals Limited | -791.91 Million INR | 184.733% |
| OXYGENTA PHARMACEUTICAL LIMITE | 571.32 Million INR | -17.448% |
| Godavari Drugs Limited | 530.02 Million INR | -26.601% |
| SHAMROCK INDUSTRIAL CO.LTD. | -9.31 Million INR | 7307.444% |
| Ambalal Sarabhai Enterprises Limited | 132.1 Million INR | -407.958% |
| Vivanza Biosciences Limited | 50.02 Million INR | -1241.329% |
| Medi-Caps Limited | -3.21 Million INR | 20977.816% |
| DECIPHER LABS LIMITED | -93.13 Million INR | 820.45% |
| Shree Ganesh Remedies Limited | 201.85 Million INR | -232.42% |
| Gujarat Themis Biosyn Limited | -53.88 Million INR | 1345.292% |
| Bharat Parenterals Limited | 1.48 Billion INR | 54.926% |
| BDH Industries Limited | -164.47 Million INR | 507.985% |
| Vista Pharmaceuticals Limited | 78.7 Million INR | -752.578% |
| Coral Laboratories Limited | -612.82 Million INR | 209.495% |
| Evoq Remedies Limited | 41.14 Million INR | -1530.731% |
| Trinity League India Limited | -12 Thousand INR | 5591875.0% |
| KOBO BIOTECH LIMITED | 1.39 Billion INR | 51.902% |
| Natural Capsules Limited | 956.68 Million INR | 29.86% |
| Auro Laboratories Limited | 252.51 Million INR | -165.731% |